Skip to main content
. 1998 Nov;5(6):799–803. doi: 10.1128/cdli.5.6.799-803.1998

TABLE 4.

Mumps virus-specific IgG titers and avidities of patients with mumps vaccine failures

Case no. Age (yr)/sexa Age (yr) at vaccination Day of samplingb IgMc IgG
Titer (102) Avidity (%)
VF-1 8/F 3 0 Pos 30 1
VF-2 6/F 3 1 Pos 31 20
VF-3 8/M 3 0 Pos 99 47
VF-4 11/M 3 0 Pos 202 66
VF-5d 7/M 4 2 Pos 170 60
VF-6 8/M 2 2 Pos 131 56
VF-7 5/F 3 3 Pos 195 63
VF-8 7/F 1 3 Pos 115 51
VF-9de 6/F 1 5 Pos 351 86
VF-10 5/M 2 1 Neg 69 58
VF-10 5/M 2 18 Neg 337 81
VF-11 5/M 4 1 Neg 134 59
VF-12 5/F 1 5 Neg 169 57
VF-13d 8/M 1 5 Neg 198 63
VF-14d 11/M 2 8 Neg 219 52
a

M, male; F, female. 

b

The day on which parotid gland pain and/or swelling was first noticed was designated day 0. 

c

Pos, positive; Neg, negative. 

d

Complicated by aseptic meningitis. 

e

Mumps virus was detected in the cerebrospinal fluid by PCR.